<p>The National Human Genome Research Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $20,995.00 on June 12, 2019, with performance concluding July 31, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is for firm fixed price delivery of life science research equipment and supplies from Bio-Rad's Life Science Group Division.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $1,303.72 on December 20, 2016, with completion by December 19, 2017. The order is for laboratory supplies on a firm fixed-price basis. Performance is at Bethesda, Maryland.</p>
<p>The National Human Genome Research Institute issued a purchase order to Bio-Rad Laboratories, Inc. on May 19, 2016, with a ceiling value of $17,418.48 for firm fixed-price laboratory equipment and supplies. Place of performance is Bethesda, Maryland. The order ultimate completion date is December 22, 2020. No set-aside was used.</p>
The National Human Genome Research Institute awarded a purchase order to Bio-Rad Laboratories, Inc. valued at $10,634.31 on June 9, 2015, with an ultimate completion date of July 14, 2016. The order is firm fixed price with no small business set-aside. Performance occurs in North Bethesda, Maryland. The purchase order procures life science research and clinical diagnostics products from Bio-Rad's Life Science Group Division, including specialized laboratory equipment, reagents, and consumables...
<p>The National Human Genome Research Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for maintenance agreement services on a PCR system valued at $22,955.00, with an award date of July 15, 2026 and ultimate completion date of July 14, 2027. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside applied.</p>
The National Institutes of Health National Human Genome Research Institute awarded a $10,569.94 firm fixed price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for a gel imaging system. The equipment will support the agency's genotyping workload through June 2024. No set-aside designation was specified. Bio-Rad will deliver the system under its existing $1 billion blanket purchase agreement with the Department of Health and Human Services National Institutes of Health...
The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a $18,829.73 firm-fixed-price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for a digital PCR system with an auto-loading feature and a one-year full on-site support plan. The contract, which has a completion date of July 31, 2021, was not set aside for any specific business category. Bio-Rad Laboratories, Inc. is a leading manufacturer of...
This federal contract award to Bio-Rad Laboratories, Inc. (a large, for-profit manufacturer of life science research and diagnostic products) for $16,705.34 was issued by the National Human Genome Research Institute, a component of the National Institutes of Health. The contract, a firm fixed-price purchase order, provides for the delivery of unspecified products or services, as there was no set-aside designation. Bio-Rad Laboratories holds a $1 billion Blanket Purchase Agreement with the NIH to...
Bio-Rad Laboratories, Inc., through its Life Science Group Division, was awarded a $4,955 firm fixed-price Blanket Purchase Agreement (BPA) call by the National Human Genome Research Institute (NHGRI) on May 31, 2017, with an ultimate completion date of June 30, 2017. This contract was executed without a small business set-aside designation and was performed at the NHGRI facility in Bethesda, Maryland. The award represents a call order against Bio-Rad's broader procurement relationship with...
Bio-Rad Laboratories, Inc.'s Life Science Group Division was awarded a $23,350 firm fixed-price call order under a blanket purchase agreement with the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health. The contract, finalized on August 27, 2014, with an ultimate completion date of October 27, 2014, involved the procurement of biological materials, blood products, chemicals, laboratory supplies, and medical/veterinary/surgical supplies to support...